|
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
RECRUITINGSponsored by Maastricht University Medical Center
Actively Recruiting
SponsorMaastricht University Medical Center
Started2021-03-16
Est. completion2027-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT07717437
Summary
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Patients who have undergone PVE/HVE or technical variations on this procedure * 18 Years and older * Men and women
Conditions4
CancerLiver CancerLiver DiseaseLiver Metastases
Locations3 sites
Illinois
1 siteRush University Medical Center
Minnesota
1 siteMayo Clinic
Ohio
1 siteCleveland Clinic
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMaastricht University Medical Center
Started2021-03-16
Est. completion2027-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT07717437